Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rowan, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rowan, A. J.
NEUROLOGY 1998;51:S28-S33
© 1998 American Academy of Neurology

Reflections on the treatment of seizures in the elderly population

A. James Rowan, MD

From the Department of Neurology, Mount Sinai School of Medicine, and the Neurology Service, Bronx VA Medical Center, Bronx, NY.

Address correspondence and reprint requests to Dr. A. James Rowan, Neurology Service, Department of Veterans Affairs Medical Center, 130 West Kingsbridge Road, Bronx, NY 10468.

Abstract.

Treatment of seizure disorders in older patients is an important problem because of the age-related increase in seizure incidence and the growing size of this segment of the population. Physiologic changes that occur with aging may influence drug dosing and safety. The standard antiepileptic drugs (AEDs) are not ideal for treating older patients because of their complex pharmacokinetics, multiple drug interactions, and possible increased susceptibility to adverse effects. Data are limited on the use of the newer AEDs-gabapentin, lamotrigine, topiramate, and tiagabine-in older patients. An ongoing clinical trial in this population is investigating the efficacy and safety of gabapentin and lamotrigine relative to carbamazepine for the treatment of new-onset partial seizures. Other trials are needed to evaluate the use of topiramate and tiagabine in older patients with epilepsy. In the absence of these data, AED selection in older patients must be made on the basis of current knowledge of efficacy and safety profiles. The newer agents now offer increased therapeutic options and some theoretical advantages over the older AEDs for elderly persons with seizures.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by AAN Enterprises, Inc.